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Abstract Xanthogranulomatous pyelonephritis (XGP) is characterized by the presence of lipid-
laden foamy macrophages with both acute and chronic phase inflammatory cells. The 
aim of the study is to present our experience about patients with Xanthogranulomatous 
pyelonephritis. 29 patients were evaluated through a complete anamnesis and the 
preoperative management included routine blood and biochemical tests, urine culture and 
renal ultrasound, intravenous urography and computed tomography (CT). All patients 
underwent open nephrectomy followed by the pathological exam. The main symptoms of 
these patients were fever and flank pain. Preoperative laboratory tests revealed anemia, 
leukocytosis and increasing levels of blood urea nitrogen (BUN) and creatinine. Kidney 
failure was noticed in almost half of the cases. This study succeeded to evaluate the 
demographic, clinical, biological, surgical and histological characteristics. A 
pathological diagnosis is mandatory mainly for the evaluation of its coexistence with 
renal carcinoma. 
Keywords  Xanthogranulomatous pyelonephritis, urinary tract infection, E. Coli, anemia, 
leukocytosis, nephrectomy 
Highlights  Xanthogranulomatous pyelonephritis (XGP) occurs due to recurrent chronic infection 
secondary to renal lithiasis and it is frequently underdiagnosed due to its unspecific 
symptoms which mimic other conditions. 
 CT is considered the imaging technique of choice in the diagnosis of the disease 
preoperatively and a plethora of CT characteristics have been described so far. 
 A diagnosis of certainty is mandatory to be pathological, which is useful not only in the 
confirmation of the disease, but also in the evaluation of its coexistence with renal 
carcinoma.   
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Introduction 
Xanthogranulomatous pyelonephritis (XGP) is a 
chronic inflammation of the renal parenchyma, which was 
first described in 1916 by Schlagenhaufer and it occurs in 
approximately 1% of all renal infections. Two major 
forms can be recognized: diffuse and focal (1). Some 
authors also describe the segmental xanthogranulomatous 
pyelonephritis which involves only a segment of the 
kidney. The diffuse form can be easily confused with a 
severe abscess or pyonephrosis, while the focal form is 
called pseudotumoral because it is usually confused with 
a renal tumor.  
It generally occurs due to recurrent chronic infection 
secondary to renal lithiasis which usually leads to 
obstruction. The infection is usually associated with 
Proteus or E. Coli, but Pseudomonas is also frequently 
involved (2). Other agents identified are Staphylococcus 
aureus, Candida, Bacteroides, group B Streptococcus or 
Klebsiella. Although nephrolithiasis is usually present, it 
is not mandatory for diagnosis. The xanthogranulomatous 
pyelonephritis behaves like a pseudo tumor capable of 
local invasion and destruction, starting with the kidney, 
continuing with perinephric fat and, if left untreated, 
involving the adjacent retroperitoneal structures (3, 4). 
Histologically, the condition is characterized by the 
presence of lipid-laden foamy macrophages with both 
acute and chronic phase inflammatory cells. Focal 
abscesses may be present.  
In most cases, men are affected less than women, with 
a female to men ratio of 5:1 (5). Regarding the 
preoperative diagnosis, XGP is frequently underdiagnosed 
due to its unspecific symptoms which mimic other 
conditions such as perinephric abscess, pyelonephritis or 
renal tuberculosis. There is no single clinical or radiologic 
element of diagnosis specific to xanthogranulomatous 
pyelonephritis (6). Symptoms include fever, flank pain, 
lower urinary tract symptoms, hematuria or weight loss. 
30% of patients presented complications such as 
paranephric abscess, nephrocolonic or nephrocutaneous 
fistula (7).  
Usually, the transabdominal ultrasound evaluation is 
used to assess the disease. Signs such as hydronephrosis, 
less parenchymal tissue, staghorn calculus, often indicate 
a diffuse form, while there are no specific lesions for a 
focal form. CT findings are strong indicators that reveal 
helpful information about local and regional involvement. 
Nowadays, CT is considered the chosen imaging 
procedure for the preoperative diagnosis of the disease, 
numerous CT characteristics having been described so far. 
The most typical CT features of XGP should be 
considered: low-density fluid-filled areas within the renal 
parenchyma and additional elements indicating 
perinephric extension. Studies describe the MRI 
evaluation as a sensitive method in identifying lipid-laden 
foamy macrophages (6). 
The treatment for the diffuse form of the disease is 
usually nephrectomy. For the focal form, patients who 
have contraindications for surgery or bilateral form of the 
disease, antibiotics are the key to the treatment if there is 
any diagnosis based on biopsy or combined cytological 
and clinical features (8). The prognosis is considered 
reasonable after the treatment. Death from 
Xantogranulomatous pyelonephritis is exceedingly rare, 
although morbidity is substantial. Transitional cell 
carcinoma located in the renal pelvis has been associated 
with the disease.  
The goal of the study is to present our experience with 
patients diagnosed with XGP in our clinic and to evaluate 
the demographic, clinical, paraclinical, surgical and 
histological characteristics of this series of patients, for a 
better understanding and knowledge of the disease.  
Materials and Methods 
We conducted a retrospective observational study 
from January 2013 to December 2017 that identified 29 
patients diagnosed with XGP histologically confirmed 
who have been treated in our clinic (9). Moreover, 
patients with Xanthogranulomatous pyelonephritis 
associated with renal carcinoma have also been included. 
All patients were evaluated through a complete 
anamnestic and a rigorous physical exam. Preoperative 
management included routine blood tests and biochemical 
urine tests, summary and urinalysis (10). Also, all patients 
underwent renal ultrasound, intravenous urography and 
computerized tomography – Figure 1. Patients with low 
excretory functions at the intravenous urography 
underwent renal scintigraphy with Tc99m-DTPA to 
confirm the non-functioning kidney and to evaluate the 
function of the other kidney. Any urinary tract infection 
was treated with antibiotics before the surgical 
intervention, or depending on the severity of the case, the 
patients underwent percutaneous nephrostomy or Cook 
stent (double JJ stent) insertion.  
The parameters considered were: age, sex, complete 
blood tests, urine tests, symptoms at presentation such as 
fever and pain location, affected sides, surgical method 
and pathological exam. All collected data were analyzed 
and interpreted using Microsoft Word 2013 and Microsoft 
Excel 2013. Simple descriptive statistics were calculated 
(11-13). 
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Figure 1. CT pelvic scans in a patient with 
xathogranulomatous pyelonephritis highlighting 
the invasion of the disease 
All patients underwent nephrectomy, followed by the 
pathological exam in order to confirm the diagnosis. The 
tissue samples were placed in formaldehyde and then 
hematoxylin eosin stain was used for microscopical 
observations. The diagnosis of XGP was made due to the 
presence of diffuse or focal inflammatory processes with 
lipid-laden macrophages and chronic granulomatous 
inflammation – Figure 2. Postoperatively, the lab tests 
were repeated and the patients were carefully monitored. 
 
Figure 2. The pathological examination of XGP 
made from inflammatory lymphoplasmocitary 
infiltrate and abundant xantomate cell, HE stain 
Results and Discussions 
The statistical analysis of our database comprising 29 
patients treated in our hospital revealed that there were 25 
women (86.2%) and only 4 men (13.8%), with a female to 
male ratio of 6.1:1, with a mean age of 54.93 years – 
Table 1. More than a half (51.72%) were aged between 40 
and 60, over one third (37.93%) between 60 and 80 and 
only 10.34% were aged under 40, similar results being 
reported in a study performed in Argentina (14). 
Table 1. Patients Characteristics 
Mean Age 54.95 years 
 % no 
Sex M 13.79% 4 
 F 86.2% 25 
Symptoms Fever Yes 55.17% 16 
  No 44.82% 13 
 Flank 
Pain 
Yes  89.65% 26 
  No 10.34% 3 
Associated 
lithiasis 
Yes 72.41% 21 
 No 27.58% 8 
Affected side Left 44.82% 13 
 Right 55.17% 16 
Urine culture Positive 62.06% 18 
 Negative 37.93% 11 
As many authors consider, the main symptoms are 
flank pain and fever. In our study, unilateral flank pain 
was the main presentation symptom (89.65%) followed 
by fever (55.17%). In more than a half (51.72%) of the 
patients, flank pain and fever coexisted at first 
presentation. Close values are found in related studies (2). 
The pain of XGP is not colicky in nature; it is usually dull 
and persistent (15). 
In the following chart, we noted that the main 
symptom for which patients were admitted to our hospital 
was a combination of fever and flank pain in 15 cases, 
flank pain in only 11 cases, two of them being 
asymptomatic and one presenting fever only – Figure 3.  
 
Figure 3. Column chart representing the 
patients’ symptoms at presentation 
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Preoperative lab test revealed anemia in 19 patients, 
leukocytosis in 15 patients and increasing levels of blood 
urea nitrogen and creatinine in 13 cases. The mean 
hemoglobin value before surgery was 11.5 ± 1.9 g/dL, 
and the mean value of leukocytes was 10.6 ± 3.6 x 
103/μL. One mechanism of anemia suggested by 
Goodman and co. (16) would be a defect in the 
reutilization of iron. 
As shown in Table 2, the simultaneous presence of 
anemia and leukocytosis was noticed in more than one 
third of the patients, but also a high number of patients 
did not present anemia nor leukocytosis. 
A creatinine increase over 1.0 mg/dL (F) and over 1.2 
mg/dL (M) was detected preoperatively in 13 patients 
(44.82%). The mean level of creatinine was 1.03 ± 0.26 
mg/dL, and the mean level of GFR was 63 ± 18 
mL/min/1.73 m2. Kidney failure was noticed in 13 
(44.82%) out of the 29 cases with a GFR < 60 
mL/min/1.73 m2, but more than half of the patients 
(55.17%) presented normal kidney function. 
Table 2. Modifications of the complete blood count 
Modifications no % 
Anemia & 
Leukocytosis 
11 37.93 
Only Anemia 8 27.59 
Only 
Leukocytosis 
4 13.79 
Neither 
Anemia nor 
Leukocytosis 
6 20.69 
The urine culture was positive in 18 patients (62.06%) 
and negative in over one third of them (37.84%). In 16 
out of the 18 cases with positive urine culture, a Gram-
negative microorganism from the Enterobacteriaceae 
family was detected, while Gram-positive 
microorganisms were detected in only two cases (6.89%). 
Our findings are consistent with those reported by a study 
conducted in Greece (17), in terms of the urine culture 
results. 
As shown in the following column chart – Figure 4, 
the most frequent microorganism identified was E. Coli, 
followed by Proteus, Klebiella, Enterococcus and 
Staphylococcus, while a significant number of patients 
had sterile urine. 
 
Figure 4. The distributions of the uropathogens 
identified in urine cultures 
In the following column chart – Figure 5, the strong 
relationship between renal lithiasis and/or urinary tract 
infections in association with Xanthogranulomatous 
pyelonephritis is represented. 
 
Figure 5. The association of urinary tract 
infections (UTI) and renal lithiasis in the study 
group 
Our study limitations reside in the retrospective 
observational nature, the lack of standardized protocol, 
the progression of the chronic renal disease after the 
surgical treatment that could not been demonstrated and 
the low number of cases presented in the study in 
accordance with the disease prevalence. 
It is generally accepted that XGP is caused by a 
combination of diseases which includes obstructive 
lithiasis and chronical infections (5). Persistent stasis 
yields recurrent infections with subsequent coagulative 
necrosis and destruction of the renal parenchyma. In our 
study, renal lithiasis was found in 21 cases (72.41%), 
which is a strong argument to support the etiopathogenic 
theory, but we also enrolled 2 patients in which no urinary 
tract infection or renal calculi were found. 
The inflammatory process affects the whole kidney, 
the focal forms being extremely seldom discovered (18-
20). Owing to its heterogeneous appearance, XGP can 
easily be confused with renal cell carcinoma and/or 
infiltrating urothelial carcinoma of the renal pelvis. There 
are no findings to support the idea of a bilateral disease, 
and no predilection for one side only, the percentages 
Xanthogranulomatous pyelonephritis 
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being almost equal for both left or right sides (7). In this 
study, we had 16 cases of xantogranulomatous 
pyelonephritis located on the right side (55.17%), but the 
number of cases and the low percentage cannot support 
the predominance of this side. 
The treatment for XGP is surgical, including open or 
laparoscopic nephrectomy. Because of the clinical and 
paraclinical exam, preoperative care should be 
considered, and it often includes antibiotics and renal 
drainage (by means of nephrostomy or JJ stent), in 
combination or separately (21). The authors of a study 
describe renal drainage using nephrostomy in 77.8% of 
the overall 30 cases (2). 
The preoperative treatment consisted only in 
antibiotics in 13 cases (44,82%), while in more than a half 
of the cases (55.17%) it was followed by drainage: 13 
patients (44.82%) with percutaneous nephrostomy and 3 
patients (10.34%) with JJ stent. 
Regarding the surgical approach, open nephrectomy 
was performed in 21 cases (72.41%), similar to the report 
of a study which analyzed nephrectomy in inflammatory 
renal disease in Brazil (22). Laparoscopic nephrectomy 
was performed in 7 cases (24.13%) and partial 
nephrectomy was the treatment of choice in only one case 
(3.44%).  
The laparoscopic treatment was frequently disputed, 
but some studies describe that a good experience in 
laparoscopy can make this kind of intervention possible 
also in xantogranulomatous pyelonephritis (23). 
Laparoscopic nephrectomy for XGP is complicated and 
more technically demanding than the laparoscopic 
nephrectomy for noninfectious etiologies (24). For the 
novice laparoscopist, however, the open approach should 
remain the approach of choice.  
Postoperative blood tests revealed anemia in 25 cases 
(86.2%), leukocytosis in 12 cases (41.37 %) and the 
presence of kidney failure (eGFR <60 mL/min/1.73 m2) 
in 13 patients (44.82%).  
The examination of the excisional specimen (post-
nephrectomy) revealed the presence of 
Xanthogranulomatous pyelonephritis, with characteristic 
chronic inflammatory infiltration and lipid-laden 
macrophages in all 29 cases – Figure 6. This is in 
conformity with the results of the research conducted by 
Arvind and co. (25, 26). The pathological examination 
revealed the presence of XGP in only 23 cases (79.31%), 
but it revealed the presence of the XGP simultaneous with 
renal carcinoma in six cases (20.68%). 
 
Figure 6. The macroscopic evaluation of the 
post-nephrectomy specimen 
Conclusions 
Our study succeeded in evaluating the demographic, 
clinical, paraclinical, surgical and histological 
characteristics of this series of patients. Moreover, the 
results of the study were compared with the data from 
other studies. Xanthogranulomatous pyelonephritis affects 
mostly women (a W:M ratio up to 6:1) aged between 40 
and 70 years. 
The main symptoms are flank pain and fever, 
occasionally patients can be asymptomatic. Blood 
laboratory tests reveal mainly anemia, leukocytosis and 
kidney failure. The most frequent microorganism found in 
urine was E. Coli. The treatment was surgical 
(nephrectomy) in most cases, associated with antibiotic 
therapy. Antibiotics alone cannot control the disease, but 
associated with surgical therapy, they can prevent pre- 
and postoperative complications. 
The diagnosis of certainty is mandatory to be 
pathological, which is useful not only in the confirmation 
of the disease, but also in the evaluation of its coexistence 
with renal carcinoma.  
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